Cancer at Cedars-Sinai shared a post on X:

“‘Arsen Osipov is a co-author on the JCO ASCO paper “Tumor Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study” that was also presented at ASCO25.”

Title: Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

Authors: Hani M. Babiker, Vincent Picozzi, Sreenivasa R. Chandana, Bohuslav Melichar, Anup Kasi, Jin Gang, Javier Gallego, Andrea Bullock, Hao Chunyi, Lucjan Wyrwicz, Erika Hitre, Arsen Osipov, Christelle de la Fouchardiere, Inmaculada Ales, Tomislav Dragovich, Woojin Lee, Kynan Feeney, Philip Philip, Makoto Ueno, Eric Van Cutsem, Thomas Seufferlein, Teresa Macarulla

Read Full Article.

Arsen Osipov

More post featuring Cancer at Cedars-Sinai on OncoDaily.

Arsen Osipov Co-Authored Phase III PANOVA-3 Study Published on the JCO ASCO – Cancer at Cedars-Sinai

“‘Arsen Osipov is a co-author on the JCO ASCO paper “Tumor Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study” that was also presented at ASCO25.”